Jian Yin

813 total citations
29 papers, 610 citations indexed

About

Jian Yin is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jian Yin has authored 29 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jian Yin's work include Multiple Myeloma Research and Treatments (3 papers), Ion Transport and Channel Regulation (3 papers) and MicroRNA in disease regulation (3 papers). Jian Yin is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Ion Transport and Channel Regulation (3 papers) and MicroRNA in disease regulation (3 papers). Jian Yin collaborates with scholars based in China, United States and France. Jian Yin's co-authors include Songbai Yang, Maojun Yang, Xudong Chen, Thomas L. Beck, Zhifeng Kuang, Wenhe Wang, Jingbo Yi, Jinke Gu, Laixing Zhang and Wei Zhuo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Jian Yin

26 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Yin China 15 385 94 71 68 63 29 610
Jianfen Guo United States 16 535 1.4× 100 1.1× 67 0.9× 67 1.0× 102 1.6× 20 831
Prachi Umbarkar United States 15 363 0.9× 50 0.5× 86 1.2× 42 0.6× 49 0.8× 22 706
Vanessa F. Merino United States 18 452 1.2× 134 1.4× 145 2.0× 126 1.9× 62 1.0× 26 878
Maria Teresa Rizzo United States 13 254 0.7× 83 0.9× 128 1.8× 56 0.8× 74 1.2× 40 601
Zhirong Yang United States 16 427 1.1× 188 2.0× 63 0.9× 108 1.6× 134 2.1× 24 904
Steve L. Abrams United States 5 444 1.2× 82 0.9× 135 1.9× 48 0.7× 22 0.3× 8 625
Yan Meng China 13 241 0.6× 65 0.7× 69 1.0× 64 0.9× 18 0.3× 22 472
Fabrice Jaffré France 11 429 1.1× 35 0.4× 82 1.2× 85 1.3× 57 0.9× 17 831
Urszula Mackiewicz Poland 16 354 0.9× 42 0.4× 70 1.0× 30 0.4× 117 1.9× 59 890

Countries citing papers authored by Jian Yin

Since Specialization
Citations

This map shows the geographic impact of Jian Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Yin more than expected).

Fields of papers citing papers by Jian Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Yin. The network helps show where Jian Yin may publish in the future.

Co-authorship network of co-authors of Jian Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Yin. A scholar is included among the top collaborators of Jian Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Yin. Jian Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jing, Lei, Xue Zhang, Jian Yin, et al.. (2025). Evolution of ceftazidime-avibactam resistance driven by variation in blaKPC-2 to blaKPC-190 during treatment of ST11-K64 hypervirulent Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology. 15. 1607127–1607127.
2.
Chen, Xudong, et al.. (2024). Molecular architecture of the mammalian 2-oxoglutarate dehydrogenase complex. Nature Communications. 15(1). 8407–8407. 4 indexed citations
3.
Yi, Jingbo, Jian Yin, Xudong Chen, et al.. (2023). Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2). Nature Communications. 14(1). 7755–7755. 4 indexed citations
4.
Wang, Wenhe, Xudong Chen, Laixing Zhang, et al.. (2020). Atomic structure of human TOM core complex. Cell Discovery. 6(1). 67–67. 90 indexed citations
5.
OGASAWARA, K., Patricia LoRusso, Anthony J. Olszanski, et al.. (2020). Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach. Cancer Chemotherapy and Pharmacology. 86(1). 87–95. 12 indexed citations
6.
OGASAWARA, K., William B. Smith, Christine Xu, et al.. (2020). Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment. Cancer Chemotherapy and Pharmacology. 85(6). 1109–1117. 7 indexed citations
7.
8.
Zhang, Ying, et al.. (2019). MiR-566 mediates cell migration and invasion in colon cancer cells by direct targeting of PSKH1. Cancer Cell International. 19(1). 333–333. 9 indexed citations
9.
Liu, Feng, et al.. (2018). Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy. Kidney & Blood Pressure Research. 43(5). 1425–1436. 39 indexed citations
10.
Yang, Songbai, et al.. (2018). Blocking the REDD1/TXNIP axis ameliorates LPS-induced vascular endothelial cell injury through repressing oxidative stress and apoptosis. American Journal of Physiology-Cell Physiology. 316(1). C104–C110. 86 indexed citations
11.
Yang, Ping, An Chen, You Qin, et al.. (2018). Buyang huanwu decoction combined with BMSCs transplantation promotes recovery after spinal cord injury by rescuing axotomized red nucleus neurons. Journal of Ethnopharmacology. 228. 123–131. 24 indexed citations
12.
Yang, Songbai, et al.. (2018). Inhibition of miR-135b by SP-1 promotes hypoxia-induced vascular endothelial cell injury via HIF-1α. Experimental Cell Research. 370(1). 31–38. 33 indexed citations
13.
Zhou, Wei, Fan Jin, Bowen Wan, et al.. (2017). Endogenous Parathyroid Hormone Promotes Fracture Healing by Increasing Expression of BMPR2 through cAMP/PKA/CREB Pathway in Mice. Cellular Physiology and Biochemistry. 42(2). 551–563. 31 indexed citations
14.
Rixe, Olivier, Igor Puzanov, Patricia LoRusso, et al.. (2015). Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-Cancer Drugs. 26(7). 785–792. 2 indexed citations
15.
Yin, Jian, et al.. (2014). Mechanisms of Isoform-Specific Na/K Pump Regulation by Short- and Long-Term Adrenergic Activation in Rat Ventricular Myocytes. Cellular Physiology and Biochemistry. 33(6). 1681–1697. 4 indexed citations
16.
Li, Wei, Jian Yin, Ying Liu, et al.. (2013). Anti-colon carcinoma cell activity of ginsenosides from the acid hydrolysate of Panax ginseng. Chemistry of Natural Compounds. 48(6). 1017–1020. 6 indexed citations
17.
Zhang, Linan, Fang Guo, Suwen Su, et al.. (2011). Na+/K+‐ATPase inhibition upregulates NMDA‐evoked currents in rat hippocampal CA1 pyramidal neurons. Fundamental and Clinical Pharmacology. 26(4). 503–512. 14 indexed citations
18.
Zhang, Linan, Fang Guo, Huicai Guo, et al.. (2010). The Paradox of Dopamine and Angiotensin II-Mediated Na+, K+-ATPase Regulation in Renal Proximal Tubules. Clinical and Experimental Hypertension. 32(7). 464–468. 8 indexed citations
19.
Qin, Meng, et al.. (2009). A new panaxadiol from the acid hydrolysate of Panax ginseng. Chinese Chemical Letters. 20(6). 687–689. 18 indexed citations
20.
Yin, Jian, et al.. (2004). Ion transit pathways and gating in ClC chloride channels. Proteins Structure Function and Bioinformatics. 57(2). 414–421. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026